OrbiMed’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-336,300
| Closed | -$105M | – | 124 |
|
|
2025
Q2 | $105M | Buy |
336,300
+135,100
| +67% | +$51.6M | 2.62% | 12 |
|
|
2025
Q1 | $105M | Buy |
201,200
+70,300
| +54% | +$35.9M | 2.51% | 10 |
|
|
2024
Q4 | $66.2M | Sell |
130,900
-48,100
| -27% | -$27.3M | 1.36% | 24 |
|
|
2024
Q3 | $105M | Buy |
179,000
+67,000
| +60% | +$37.9M | 1.9% | 14 |
|
|
2024
Q2 | $57M | Buy |
112,000
+42,000
| +60% | +$20.6M | 1.13% | 28 |
|
|
2024
Q1 | $34.6M | Hold |
70,000
| – | – | 0.63% | 48 |
|
|
2023
Q4 | $36.9M | Hold |
70,000
| – | – | 0.74% | 46 |
|
|
2023
Q3 | $35.3M | Sell |
70,000
-174,000
| -71% | -$85.6M | 0.75% | 49 |
|
|
2023
Q2 | $117M | Sell |
244,000
-32,000
| -12% | -$15.6M | 2.13% | 10 |
|
|
2023
Q1 | $130M | Sell |
276,000
-104,500
| -27% | -$50.4M | 2.56% | 10 |
|
|
2022
Q4 | $202M | Buy |
380,500
+113,300
| +42% | +$60M | 3.86% | 2 |
|
|
2022
Q3 | $135K | Sell |
267,200
-14,000
| -5% | -$7.36M | 2.51% | 8 |
|
|
2022
Q2 | $144K | Sell |
281,200
-13,000
| -4% | -$6.53M | 2.62% | 8 |
|
|
2022
Q1 | $150M | Buy |
294,200
+23,200
| +9% | +$11.2M | 2.43% | 9 |
|
|
2021
Q4 | $136M | Sell |
271,000
-118,700
| -30% | -$53.7M | 1.75% | 16 |
|
|
2021
Q3 | $152M | Hold |
389,700
| – | – | 1.67% | 18 |
|
|
2021
Q2 | $156M | Sell |
389,700
-13,300
| -3% | -$5.3M | 1.58% | 17 |
|
|
2021
Q1 | $150M | Buy |
403,000
+12,700
| +3% | +$4.4M | 1.4% | 19 |
|
|
2020
Q4 | $137M | Buy |
+390,300
| New | +$131M | 1.2% | 20 |
|
|
2019
Q1 | – | Sell |
-186,500
| Closed | -$46.5M | – | 141 |
|
|
2018
Q4 | $46.5M | Hold |
186,500
| – | – | 0.86% | 40 |
|
|
2018
Q3 | $49.6M | Buy |
186,500
+63,200
| +51% | +$16.4M | 0.6% | 51 |
|
|
2018
Q2 | $30.3M | Buy |
+123,300
| New | +$29.6M | 0.36% | 65 |
|
|
2018
Q1 | – | Sell |
-239,500
| Closed | -$52.8M | – | 148 |
|
|
2017
Q4 | $52.8M | Sell |
239,500
-140,500
| -37% | -$29.8M | 0.67% | 46 |
|
|
2017
Q3 | $74.4M | Sell |
380,000
-48,600
| -11% | -$9.39M | 0.71% | 41 |
|
|
2017
Q2 | $79.5M | Buy |
428,600
+132,200
| +45% | +$23.2M | 0.83% | 39 |
|
|
2017
Q1 | $48.6M | Hold |
296,400
| – | – | 0.55% | 53 |
|
|
2016
Q4 | $47.4M | Sell |
296,400
-315,400
| -52% | -$47.1M | 0.6% | 49 |
|
|
2016
Q3 | $85.7M | Sell |
611,800
-596,400
| -49% | -$83.5M | 0.98% | 38 |
|
|
2016
Q2 | $171M | Buy |
1,208,200
+396,200
| +49% | +$52.8M | 1.78% | 17 |
|
|
2016
Q1 | $105M | Buy |
812,000
+574,000
| +241% | +$67.9M | 1.1% | 30 |
|
|
2015
Q4 | $28M | Hold |
238,000
| – | – | 0.25% | 66 |
|
|
2015
Q3 | $27.6M | Hold |
238,000
| – | – | 0.28% | 63 |
|
|
2015
Q2 | $29M | Buy |
238,000
+3,000
| +1% | +$355K | 0.24% | 72 |
|
|
2015
Q1 | $27.8M | Hold |
235,000
| – | – | 0.24% | 68 |
|
|
2014
Q4 | $23.8M | Buy |
235,000
+35,000
| +18% | +$3.32M | 0.23% | 69 |
|
|
2014
Q3 | $17.3M | Buy |
+200,000
| New | +$16.9M | 0.18% | 81 |
|
|
2014
Q2 | – | Sell |
-102,000
| Closed | -$8.36M | – | 145 |
|
|
2014
Q1 | $8.36M | Sell |
102,000
-689,000
| -87% | -$51.9M | 0.1% | 100 |
|
|
2013
Q4 | $59.6M | Sell |
791,000
-538,000
| -40% | -$38.6M | 0.88% | 34 |
|
|
2013
Q3 | $95.2M | Buy |
1,329,000
+121,000
| +10% | +$8.66M | 1.7% | 22 |
|
|
2013
Q2 | $79.1M | Buy |
+1,208,000
| New | +$75.2M | 1.68% | 22 |
|
Other funds holding UNH
OrbiMed's UNH Position: Q3 2025 in Review
OrbiMed sold out of UnitedHealth (UNH) in Q3 2025, closing a stake of 336,300 shares — an estimated $105M sold.
OrbiMed first reported a position in UNH in Q2 2013 and held it in 40 quarters. The position peaked at $202M in Q4 2022. 3,160 funds tracked by Wall St. Rank hold UNH as of Q3 2025.
- OrbiMed reported no remaining UnitedHealth position as of Q3 2025 after selling out during the quarter.
- OrbiMed sold 336,300 UnitedHealth shares in Q3 2025, an estimated $105M.
- OrbiMed first reported a position in UnitedHealth in Q2 2013 and held it in 40 quarters.
- OrbiMed's UnitedHealth position peaked at $202M in Q4 2022.
- 3,160 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2025.
Based on OrbiMed's 13F filing for Q3 2025, filed 14 Nov 2025.